Basel, Switzerland

Frederic Bassilana


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Inventor Frederic Bassilana

Introduction

Frederic Bassilana, an accomplished inventor based in Basel, Switzerland, has made significant contributions to the field of organic compounds. With a unique focus on medical treatment methods, his innovations stand out in the landscape of modern medicinal chemistry.

Latest Patents

Frederic Bassilana holds a patent related to modulators of the interaction between G-protein coupled receptor 15 (GPR15) and c10orf99. This invention encompasses a modulator that may be a small chemical molecule, antibody, or other therapeutic protein. Additionally, the patent describes methods for medical treatment and identifying modulators, demonstrating innovation in pharmaceutical applications.

Career Highlights

Throughout his career, Frederic has been associated with notable companies in the pharmaceutical sector. He worked with Novartis AG, a global leader in healthcare and pharmaceuticals, where his expertise contributed to important projects. He also spent time at Odega SA, further demonstrating his versatility and commitment to advancing medical science.

Collaborations

Frederic has collaborated with esteemed professionals in his field, including Birgit Uta Baumgarten and Nathalie Marie-Therese Carte. These partnerships highlight his ability to work alongside prominent figures in the industry, fostering innovation through teamwork and shared expertise.

Conclusion

Frederic Bassilana's contributions to organic compounds and therapeutic innovations underscore his dedication to improving medical treatments. With one patent to his name and experience in leading pharmaceutical companies, he represents a significant figure in the realm of invention, demonstrating the impact of collaborative endeavors and cutting-edge research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…